Skip to content
Clinical Trials – home

Huisarten Praktijk Rambharose

Research site

The Netherlands Kempstraat 230, 2572 GM Hague, The Netherlands

  • COVID-19
  • Adults and children

About Specializations

Huisarten Praktijk Rambharose in Hague, The Netherlands specialises in clinical trials of conditions such as COVID-19, and other specialisations. This site conducts important research.

Main research areas of the site

Infectious Diseases

The medical center is at the forefront of research in infectious diseases, with a particular focus on developing innovative treatments for viral infections. The ongoing study on bemnifosbuvir highlights the center's commitment to addressing global health challenges.

  • COVID-19 Treatment
  • Antiviral Drug Development
  • Outpatient Care Strategies

By evaluating the efficacy of bemnifosbuvir in reducing hospitalization and mortality in high-risk COVID-19 patients, the center contributes significantly to the advancement of therapeutic options for managing viral outbreaks.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Kempstraat 2302572 GM HagueThe Netherlands
Recruiting now
no trials
Conditions studied
1

More sites in HagueThe Netherlands

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

1 clinical trial

COVID-19

Not recruiting

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Atea Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.